Home/Assertio Holdings/John B. Golubieski
JB

John B. Golubieski

Strategic Advisor, Former Interim CEO

Assertio Holdings

Assertio Holdings Pipeline

DrugIndicationPhase
INDOCIN SuppositoriesPatent Ductus Arteriosus (PDA)Approved
INDOCIN OralRheumatoid Arthritis, Osteoarthritis, GoutApproved
OtrexupRheumatoid Arthritis, PsoriasisApproved
ROLVEDONChemotherapy-induced NeutropeniaApproved
SYMJEPIAnaphylaxisApproved
Pipeline CandidateUndisclosedUndisclosed